PeptideAnswerPeptideAnswerAsk a question
Skin & Cosmetic

Matrixyl

Also called palmitoyl pentapeptide-4, pal-KTTKS

Matrixyl is a tiny fragment of collagen with a fatty tail attached so it can get through skin.

Where this answer comes fromSmall human studies

Studied in people, in small numbers. The ranges below lean mostly on community-reported dosing and results — what people run, and what they say happened.

The quick answer

Matrixyl is a tiny fragment of collagen with a fatty tail attached so it can get through skin. The fragment is the same piece your skin releases when collagen breaks down - so putting it on is essentially telling your skin that collagen has been damaged and more is needed. It is a message, not an ingredient.

What it is not

Not a retinoid, and not a substitute for sun protection.

Why people use it

🧴 Topical - no injection at all; ✨ Fine lines and firmness over months; 🤝 Layers with almost everything; 😌 Tolerated by people who cannot use retinoids

What people report using

These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.

Skin & hair3–8%
How often
Twice daily
Route
topical
Evidence for this
Small human studies

Fine lines and firmness over two to three months.

What to expect, and when

Month 1: hydration and texture. Month 2-3: fine lines. Month 4-6: firmness, which is where before-and-after photos start to show it.

Side effects, and what people do about them

Among the gentlest actives in skincare. Occasional irritation, usually traced to the rest of the formula rather than the peptide.

Go deeper

Open these only if you want them.

How it actually works

Palmitoyl pentapeptide-4 (pal-KTTKS). The KTTKS sequence is a fragment of type I collagen that signals fibroblasts to increase collagen and glycosaminoglycan synthesis; the palmitoyl tail supplies the fat solubility needed to cross the outer layer of skin.

More on the evidence

Small topical human trials. A cosmetic ingredient, not an injectable.

The case against

Small cosmetic-scale human studies, generally positive, with modest effects honestly reported.

What people report, in full

The skincare community's verdict on Matrixyl is settled, and it is worth hearing because it is unusually consistent: it works, slowly, and it is not a retinoid. The people who report disappointment are the ones who expected retinoid-scale results in a month; the people who ran it three to six months and took photographs describe real change in fine lines and firmness. Its genuine niche in the discussion is as the option for skin that cannot tolerate retinoids and for people who are pregnant, and it gets recommended for that constantly. Two practical points repeat: the concentration in the finished product matters far more than the brand name, and it layers with everything, which is why it usually shows up as a supporting ingredient rather than a headline one.

Sources and review

References

https://pubmed.ncbi.nlm.nih.gov/18492182/

Last reviewed 2026-09-08.

People also look at